| Name | JAK3/BTK-IN-5 |
|---|---|
| Synonyms | 2-Propen-1-one, 1-[(2S,4R)-4-[[5-chloro-2-[(1-ethyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]-2-methyl-1-pyrrolidinyl] |
| Description | JAK3/BTK-IN-5 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets for autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway exhibits synergistic effects. JAK3/BTK-IN-5 has the potential for the research of JAK3 kinase and/or BTK-related diseases (extracted from patent WO2021147953A1, compound 35)[1] |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C19H22ClN7O2 |
|---|---|
| Molecular Weight | 415.88 |